Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
6
6 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- EnpatoranM5049, M5049 dosePhase 35 trials
EMD Serono Research & Development Institute, Inc. · Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Systemic Lupus Erythematosus
- Precemtabart tocentecanPrecem-TcT, M9140Phase 32 trials
EMD Serono Research & Development Institute, Inc. · Metastatic Colorectal Cancer, Solid Tumors, Gastric Cancer
- M1774TuvusertibPhase 22 trials
EMD Serono Research & Development Institute, Inc. · Non-Small Cell Lung Cancer, Ovarian Cancer
- JB100Phase 21 trial
EMD Serono Research & Development Institute, Inc. · Locally Advanced or Metastatic Urothelial Carcinoma
- M6223Phase 21 trial
EMD Serono Research & Development Institute, Inc. · Locally Advanced or Metastatic Urothelial Carcinoma
- NKTR-255Phase 21 trial
EMD Serono Research & Development Institute, Inc. · Locally Advanced or Metastatic Urothelial Carcinoma
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.